✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Relay Therapeutics, Inc.

Common Name
Relay Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
202
Ticker
RLAY
Exchange
Nasdaq
Description
Relay Therapeutics Inc. is a clinical-stage precision medicines company focused on discovering and developing small-molecule therapies for oncology and genetic disease. The company uses its proprietar...

Relay Therapeutics's Revenues Data

Explore Relay Therapeutics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
15,355,000a
10,007,000a
25,546,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Relay Therapeutics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Relay Therapeutics's 10-K 2025